Dr. Vinck - Verplaetse SRL
Dr. Vinck - Verplaetse reported total assets of 624,828 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Aug 2026).
By total assets for 2025, Dr. Vinck - Verplaetse ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Dr. Vinck - Verplaetse shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +181 % Total assets +57 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Dr. Vinck - Verplaetse's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 172,797 € | ||||
| Equity | 389,298 € | ||||
| Cash | 211,961 € | ||||
| EBITDA | 300,155 € | ||||
| Total assets | 624,828 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Aug 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 18 Jul 2024
- Year ended 31 Dec 2022filed on 27 Jul 2023
- Year ended 31 Dec 2021filed on 22 Sep 2022
Dr. Vinck - Verplaetse's financial analysis
- Solvency62.3%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Dr. Vinck - Verplaetse
Dr. Vinck - Verplaetse's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0463.732.155
- VAT number
- BE0463732155
- Peppol
- Registered · 0208:0463732155 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 15 Jul 1998
- Registered office
- 9770 Kruisem
- Latest accounts
- 2025 · filed on 25 Aug 2026
- Activity
- Medical specialists activities (NACE 86220)
Dr. Vinck - Verplaetse (SRL) has been based in Kruisem since 1998, active in: medical specialists activities. For 2025, it reports a net profit of 172,797 € and equity of 389,298 €; its revenue is not published. Its solvency stands at 62.3%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Dr. Vinck - Verplaetse
Companies in the same business, of comparable size and area, outside its group.
Frequently asked questions about Dr. Vinck - Verplaetse
What is the revenue of Dr. Vinck - Verplaetse?
Dr. Vinck - Verplaetse files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Dr. Vinck - Verplaetse?
In Belgium, the VAT number is the company number prefixed with BE: BE0463732155 for Dr. Vinck - Verplaetse, if the company is VAT-registered. Its company number (CBE) is 0463.732.155.
Where is the registered office of Dr. Vinck - Verplaetse?
According to the CBE register, the registered office of Dr. Vinck - Verplaetse is in 9770 Kruisem.
What is the equity of Dr. Vinck - Verplaetse?
At the close of the 2025 financial year, the equity of Dr. Vinck - Verplaetse amounts to 389,298 €, a solvency of 62.3% of total assets.
Who manages Dr. Vinck - Verplaetse?
The register lists 2 active mandates at Dr. Vinck - Verplaetse. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Dr. Vinck - Verplaetse within its sector?
By total assets for 2025, Dr. Vinck - Verplaetse ranks in the top half of the 15,434 companies in its sector (NACE 8622) in Belgium that filed accounts for that financial year.
The full file of Dr. Vinck - Verplaetse
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →